Annual Current Liabilities
$35.81 M
+$30.04 M+519.74%
September 30, 2024
Summary
- As of February 8, 2025, CTXR annual total current liabilities is $35.81 million, with the most recent change of +$30.04 million (+519.74%) on September 30, 2024.
- During the last 3 years, CTXR annual current liabilities has risen by +$31.83 million (+799.35%).
- CTXR annual current liabilities is now at all-time high.
Performance
CTXR Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$35.81 M
+$31.66 M+762.57%
September 30, 2024
Summary
- As of February 8, 2025, CTXR quarterly total current liabilities is $35.81 million, with the most recent change of +$31.66 million (+762.57%) on September 30, 2024.
- Over the past year, CTXR quarterly current liabilities has increased by +$31.66 million (+762.57%).
- CTXR quarterly current liabilities is now at all-time high.
Performance
CTXR Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CTXR Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +519.7% | +762.6% |
| 3 y3 years | +799.4% | +762.6% |
| 5 y5 years | +677.3% | +762.6% |
CTXR Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +799.4% | at high | +790.5% |
| 5 y | 5-year | at high | +799.4% | at high | +1100.0% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Citius Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $35.81 M(+519.7%) | $35.81 M(+762.6%) |
| Jun 2024 | - | $4.15 M(-0.5%) |
| Mar 2024 | - | $4.17 M(-25.2%) |
| Dec 2023 | - | $5.58 M(-3.5%) |
| Sep 2023 | $5.78 M(+27.6%) | $5.78 M(-0.2%) |
| Jun 2023 | - | $5.79 M(-6.7%) |
| Mar 2023 | - | $6.21 M(+36.9%) |
| Dec 2022 | - | $4.54 M(+0.2%) |
| Sep 2022 | - | $4.53 M(+1.5%) |
| Sep 2022 | $4.53 M(+13.8%) | - |
| Jun 2022 | - | $4.46 M(+10.9%) |
| Mar 2022 | - | $4.02 M(-45.2%) |
| Dec 2021 | - | $7.34 M(+84.4%) |
| Sep 2021 | $3.98 M(-2.8%) | $3.98 M(+10.6%) |
| Jun 2021 | - | $3.60 M(+20.6%) |
| Mar 2021 | - | $2.98 M(-15.9%) |
| Dec 2020 | - | $3.55 M(-13.4%) |
| Sep 2020 | $4.10 M(-11.1%) | $4.10 M(+13.5%) |
| Jun 2020 | - | $3.61 M(+16.0%) |
| Mar 2020 | - | $3.11 M(-14.3%) |
| Dec 2019 | - | $3.63 M(-21.2%) |
| Sep 2019 | $4.61 M(+44.7%) | $4.61 M(+14.1%) |
| Jun 2019 | - | $4.04 M(+20.1%) |
| Mar 2019 | - | $3.36 M(-13.8%) |
| Dec 2018 | - | $3.90 M(+22.5%) |
| Sep 2018 | $3.18 M | $3.18 M(+45.4%) |
| Jun 2018 | - | $2.19 M(-14.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $2.56 M(-2.1%) |
| Dec 2017 | - | $2.62 M(+6.0%) |
| Sep 2017 | $2.47 M(-52.4%) | $2.47 M(-75.2%) |
| Jun 2017 | - | $9.97 M(+35.8%) |
| Mar 2017 | - | $7.34 M(+16.2%) |
| Dec 2016 | - | $6.32 M(+21.9%) |
| Sep 2016 | $5.18 M(+276.5%) | $5.18 M(+6.8%) |
| Jun 2016 | - | $4.85 M(+11.5%) |
| Mar 2016 | - | $4.35 M(+124.7%) |
| Dec 2015 | - | $1.94 M(+40.7%) |
| Sep 2015 | $1.38 M(-40.1%) | $1.38 M(-35.7%) |
| Jun 2015 | - | $2.14 M(+27.3%) |
| Mar 2015 | - | $1.68 M(+2.3%) |
| Dec 2014 | - | $1.65 M(-28.4%) |
| Sep 2014 | $2.30 M(>+9900.0%) | $2.30 M(+7222.9%) |
| Jun 2014 | - | $31.40 K(+25.1%) |
| Mar 2014 | - | $25.10 K(+19.5%) |
| Dec 2013 | - | $21.00 K(+42.9%) |
| Sep 2013 | $14.70 K(-68.0%) | $14.70 K(-76.3%) |
| Jun 2013 | - | $62.00 K(+7.6%) |
| Mar 2013 | - | $57.60 K(+21.5%) |
| Dec 2012 | - | $47.40 K(+3.0%) |
| Sep 2012 | $46.00 K(+90.9%) | $46.00 K(+13.3%) |
| Jun 2012 | - | $40.60 K(+20.8%) |
| Mar 2012 | - | $33.60 K(+26.3%) |
| Dec 2011 | - | $26.60 K(+10.4%) |
| Sep 2011 | $24.10 K | $24.10 K(+14.2%) |
| Jun 2011 | - | $21.10 K |
FAQ
- What is Citius Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals annual current liabilities year-on-year change?
- What is Citius Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals quarterly current liabilities year-on-year change?
What is Citius Pharmaceuticals annual total current liabilities?
The current annual current liabilities of CTXR is $35.81 M
What is the all time high annual current liabilities for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high annual total current liabilities is $35.81 M
What is Citius Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, CTXR annual total current liabilities has changed by +$30.04 M (+519.74%)
What is Citius Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of CTXR is $35.81 M
What is the all time high quarterly current liabilities for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high quarterly total current liabilities is $35.81 M
What is Citius Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, CTXR quarterly total current liabilities has changed by +$31.66 M (+762.57%)